IMS offers insight to new commercial model and launch excellence initiatives.
As the industry raises the bar once again to protect human health and the environment against chemical substances, Ali S. Faqi discusses the implications of the REACH initiative for manufacturers of chemical substances.
As companies continue to magnify their efforts in the realms of manufacturing, Jeffrey L. Mooney highlights the importance in utilizing sufficient surface technologies.
Dave Shanahan shows us how a country as relatively small as Ireland continues to push the industry in every possible context Ė and with the biggest possible heart.
Mike Butler explains how Xceleron is helping its clients to answer critical clinical development questions.